| Vol. 23.06 – 28 February, 2022 |
| |
|
|
| Researchers showed that viral delivery of GDNF to the striatum, in conjunction with homotopic transplantation of human pluripotent stem cell-derived midbrain dopamine (mDA) neurons, recapitulated brain-wide mDA target innervation. [Cell Stem Cell] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists showed that functional CAR T cells could be generated within 24 hours from T cells derived from peripheral blood without the need for T cell activation or ex vivo expansion . [Nature Biomedical Engineering] |
|
|
|
| In CARTITUDE-1, 5% of patients with multiple myeloma reported movement and neurocognitive treatment-emergent adverse events with ciltacabtagene autoleucel, a B cell maturation antigen-targeted CAR T cell therapy. [Blood Cancer Journal] |
|
|
|
| Researchers studied the influence of anthropometric and body composition measurements on CAR-T-related immunotoxicity in 64 patients receiving CD19-directed CAR-T for relapsed/refractory B cell malignancies. [Haematologica] |
|
|
|
| The authors evaluated the prevalence of key vascular complications and graft-versus-host disease among 122 pediatric patients with an allogeneic hematopoietic stem cell transplantation between 2001 and 2013. [Bone Marrow Transplantation] |
|
|
|
| Scientists proposed adoptive transfer of SARS-CoV-2-specific T cells made resistant to a common immunosuppressant, Tacrolimus, for optimized performance in the immunosuppressed patient. [Molecular Therapy-Methods & Clinical Development] |
|
|
|
| To improve CAR-T therapy for glioblastoma, a new TanCAR, comprising the tandem arrangement of IL13 and EphA2 scFv, was generated and validated in vitro and in vivo. [Molecular Therapy-Oncolytics] |
|
|
|
| The authors reported a new strategy of blocking the CD7 antigen on the T cell surface with a recombinant anti-CD7 antibody to obtain a sufficient amount of CD7-targeting CAR-T cells for T cell acute lymphoblastic leukemia treatment. [Molecular Therapy-Oncolytics] |
|
|
|
| In patients achieving a complete response transcriptomic profiles of bone marrow prior to lymphodepletion showed genes mainly involved in T cell activation. [Scientific Reports] |
|
|
|
| The macroscopic view and histological sections revealed that the articular cartilage in the normal saline group was damaged, inflamed, uneven and thin, and had hyperchromatic cell infiltration. [Scientific Reports] |
|
|
|
|
| By harnessing the chemokine system and taking into consideration the chemokine expression profile in the tumor microenvironment, CAR-T cells may be homed into tumors to facilitate direct tumor cell cytolysis. [Cell Reports Medicine] |
|
|
|
| Scientists discuss recent studies and emerging research aimed to extend CAR-based therapies beyond oncology in areas such as cardiometabolic disorders, autoimmunity, fibrosis and senescence. [Nature Metabolism] |
|
|
|
|
| Fluidigm Corporation announced a collaboration agreement with the Abu Dhabi Stem Cells Center for development of targeted stem cell therapies and research applications utilizing two Fluidigm® mass cytometry and tissue imaging technologies. [Fluidigm Corporation] |
|
|
|
| The FDA granted orphan drug designation to CYNK-101, an investigational natural killer cell-based therapy for treatment of advanced HER2/neu-positive gastric or gastroesophageal junction adenocarcinoma. [Healio] |
|
|
|
| The Wisconsin Partnership Program at the University of Wisconsin School of Medicine and Public Health announced four new awards totaling $600,000 to the school’s faculty through its New Investigator Program. [University of Wisconsin School of Medicine and Public Health] |
|
|
|
| City of Hope’s Department of Stem Cell Biology and Regenerative Medicine has received a $4.9 million grant to train the next generation of scientific leaders in basic stem cell research and its translation into novel, lifesaving treatments. [City of Hope] |
|
|
|
|
| March 19 – 23, 2022 Prague, Czech Republic & Online |
|
|
|
|
|
| BioNTech – Gaithersburg, Maryland, United States |
|
|
|
| Friedrich Miescher Institute for Biomedical Research – Basel, Switzerland |
|
|
|
| Singapore-MIT Alliance for Research and Technology (SMART) Centre – Singapore, Singapore |
|
|
|
| Babraham Institute – Babraham, England, United Kingdom |
|
|
|
| TU Dresden – Dresden, Germany |
|
|
|
|